| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/20/2010 | CN101631551A Agent for prevention and/or treatment of systemic lupus erythematosus |
| 01/20/2010 | CN101631550A Therapeutic tablet for postherpetic neuralgia and method of treating postherpetic neuralgia |
| 01/20/2010 | CN101631549A Process for production of buprenorphine pharmaceutical preparation to be applied to mouth mucosa |
| 01/20/2010 | CN101631548A Dosage regimen for COMT inhibitors |
| 01/20/2010 | CN101631547A Combination Therapies for Treating Alzheimer's Disease Using I.A. Dimebon and Dolepezil |
| 01/20/2010 | CN101631546A Use of spiro-oxindole compounds as therapeutic agents |
| 01/20/2010 | CN101631545A Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof |
| 01/20/2010 | CN101631544A Chromones as therapeutic agents |
| 01/20/2010 | CN101631543A Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers and uses thereof |
| 01/20/2010 | CN101631542A Nerve regeneration agent |
| 01/20/2010 | CN101631541A Use of aminolevulinic acid and derivatives thereof |
| 01/20/2010 | CN101631540A Bone metabolism ameliorating agent |
| 01/20/2010 | CN101631539A Compositions and kits useful for treatment of respiratory illness |
| 01/20/2010 | CN101631538A A medicament for treating chronic obstructive pulmonary disease |
| 01/20/2010 | CN101628905A C-aryl glucoside SGLT2 inhibitors and method |
| 01/20/2010 | CN101628006A Composition for disinfecting nipple skins of dairy cows |
| 01/20/2010 | CN101628005A Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| 01/20/2010 | CN101628004A Anti-coccidiosis composition for livestock |
| 01/20/2010 | CN101628003A Extract of ginkgo biloba leaves and dipyridamole composite and preparation method and application thereof |
| 01/20/2010 | CN101628002A Micronized composition containing Levonorgestrel |
| 01/20/2010 | CN101628001A Medicinal composition with anti-tumor activity and analgesic activity |
| 01/20/2010 | CN101628000A Itraconazole composition grain and preparation method thereof |
| 01/20/2010 | CN101627999A Balofloxacin composition, preparation method thereof and synthesis method of material medicament |
| 01/20/2010 | CN101627998A Loratadine-ambroxol pharmaceutical composite and liposome solid preparation thereof |
| 01/20/2010 | CN101627997A 3-amino-1-nitro-guanyl-2-piperidones and application of salts thereof in preparation of medicines for treating cardiovascular diseases |
| 01/20/2010 | CN101627996A Rabeprazole sodium composition and preparation method thereof |
| 01/20/2010 | CN101627995A Application of berberine in preventing and treating atherosclerosis |
| 01/20/2010 | CN101627994A Novel anti-tumor application of organic small-molecular compound JFD-03554 |
| 01/20/2010 | CN101627993A Liquid preparation containing fifteen compound amino acids and preparation method thereof |
| 01/20/2010 | CN101627992A Application of levo butyl phthalide in preparing brain stroke medicament |
| 01/20/2010 | CN101627991A Endurance improving agent |
| 01/20/2010 | CN101627990A Application of puerarin in preparation of medicine for treating P2X3-mediated pain/neurological disease |
| 01/20/2010 | CN101627989A Novel anti-tumor application of organic small-molecular compound JFD-03169 |
| 01/20/2010 | CN101627988A Application of structure modified products of salvianolic acid B in pharmacy |
| 01/20/2010 | CN101627987A Application of gabexate mesilate and derivatives thereof in eliminating gallstones and treating gallstone complications |
| 01/20/2010 | CN101627986A Acedofenac-paracetamol pharmaceutical composite and liposome solid preparation thereof |
| 01/20/2010 | CN101627985A Application of N-acetylcysteine in preparing medicaments for treating wound |
| 01/20/2010 | CN101627984A Application of 2-(alpha- hydroxyl amyl) potassium benzoate in preventing and/or treating senile dementia |
| 01/20/2010 | CN101627983A Medicinal composition for inhibiting angiogenesis and application thereof |
| 01/20/2010 | CN101627982A Application of isoliquiritigenin as cancer-differentiating inducer |
| 01/20/2010 | CN101627974A Once-a-day oxycodone formulations |
| 01/20/2010 | CN100582235C Use of krev alcohol in preparing tyrosinase inhibitor |
| 01/20/2010 | CN100582234C Use of krev alcohol in preparing antioxidation agent |
| 01/20/2010 | CN100582233C Method for preparing krev alcohol and use for preparing anti-acetylcholinesterase medicine |
| 01/20/2010 | CN100582123C Clexane and preparation method thereof |
| 01/20/2010 | CN100582120C 21-subunit digoxin derivative and preparation method thereof |
| 01/20/2010 | CN100582116C Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof |
| 01/20/2010 | CN100582112C 4-aminothieno [2,3-d] pyrimidine-6-carbonitrile derivatives as PDE7 inhibitors |
| 01/20/2010 | CN100582110C Cyclohexanone analog saturated triring(bridge)compound and its preparation method and uses |
| 01/20/2010 | CN100582109C Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/20/2010 | CN100582108C Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives |
| 01/20/2010 | CN100582104C Oxadiazolone derivatives as PPAR delta agonists |
| 01/20/2010 | CN100582103C 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching |
| 01/20/2010 | CN100582102C Process for preparing methylation catechin by tea |
| 01/20/2010 | CN100582101C Antitumoral agent |
| 01/20/2010 | CN100582098C Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1B (P T P 1 B) inhibitors for using as blood-sugar decreasing active ingredients for treating |
| 01/20/2010 | CN100582097C Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors |
| 01/20/2010 | CN100582093C Hydroisoindoline tachykinin receptor antagonists |
| 01/20/2010 | CN100582091C Bis-aryl sulfonamides |
| 01/20/2010 | CN100582088C Aminoalcohol derivatives |
| 01/20/2010 | CN100582087C 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative |
| 01/20/2010 | CN100582086C Compound towards target of cardiac muscle and preparation |
| 01/20/2010 | CN100582085C Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/20/2010 | CN100581621C CNS chloride modulation and uses thereof |
| 01/20/2010 | CN100581589C Radioactively labelled amino acid analogues, their preparation and use |
| 01/20/2010 | CN100581586C A rapid-acting pharmaceutical composition |
| 01/20/2010 | CN100581583C Chinese traditional medicine for external application for treating children's lax |
| 01/20/2010 | CN100581581C Technique for preparing Chinese traditional medicine and pills for clearing away heart-fire, dispersing phlegm, tranquilizing the mind, and reducing blood pressure |
| 01/20/2010 | CN100581575C Cervical spondylosis treating medicine and its preparation |
| 01/20/2010 | CN100581567C Vaginitis lotion preparation method |
| 01/20/2010 | CN100581559C Compound orally disintegrating tablet of red sage root, its preparation method and detection method |
| 01/20/2010 | CN100581558C Preparation of blood-activating and pain-stopping capsules |
| 01/20/2010 | CN100581556C Chinese traditional extraction and the function containing dammarane type four-ring triterpene sapogenin |
| 01/20/2010 | CN100581554C Abalone shell calcium complement agent |
| 01/20/2010 | CN100581552C Compound puerarin for treating cardiovascular and cerebrovascular disease |
| 01/20/2010 | CN100581551C Utilization of phosphatidylserine in the treatment of attention deficit syndrome (ADHS) |
| 01/20/2010 | CN100581550C Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| 01/20/2010 | CN100581549C Sustained-release preparation containing hydrochlorothiazide and preparation method thereof |
| 01/20/2010 | CN100581548C Citric acid Mosabily oral liquid |
| 01/20/2010 | CN100581547C Ranolazine sustained release tablets |
| 01/20/2010 | CN100581546C Medicament compound containing milrinone |
| 01/20/2010 | CN100581545C Siromosi medicinal composition and its making method |
| 01/20/2010 | CN100581544C Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction |
| 01/20/2010 | CN100581543C Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 01/20/2010 | CN100581542C Use of rotigotine for preparing medicine for treating and preventing parkinson's plus syndrome |
| 01/20/2010 | CN100581541C Utilization of extracts from racemosa rhizoma for producing estrogen-like organ-selective medicament for suppressing LHSP activity |
| 01/20/2010 | CN100581540C Isosorbide mononitrate timing quick-release and slow-release preparation |
| 01/20/2010 | CN100581539C Effective component of hedyotis diffusa and method of preparing the same and application |
| 01/20/2010 | CN100581538C Magnetic slow releasing diclofenac sodium preparation in supermolecular intercalation structure and its preparation method |
| 01/20/2010 | CN100581379C Disease-preventing liver-protecting preparation for river crab, and its preparing method |
| 01/19/2010 | USRE41084 Rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methyl propionic acid (CCI-779) and 4-dimethylamino-but-2-enoic acid(4-(3-chloro-4-fluoro-phenylamino)-3-cyano-7-ethoxy-quinol in-6-yl)amide (EKB-569); synergistic; antitumor agents |
| 01/19/2010 | US7649115 Monoamine oxidase-B inhibitors; , and/or cardiometabolic disorders ( hypertension, dyslipidemias, high blood pressure, and insulin resistance); |
| 01/19/2010 | US7649103 Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field |
| 01/19/2010 | US7649098 (E)-1-(4-((1R,2S ,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)-ethanone oxime; inflammatory and autoimmune diseases |
| 01/19/2010 | US7649097 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2010 | US7649093 Naphthalene compounds as selective estrogen receptor modulators |
| 01/19/2010 | US7649089 Biodegradable oxidized cellulose esters and their uses as microspheres |
| 01/19/2010 | US7649087 Saccharide residue-functional organopolycarbosiloxanes and method for the preparation thereof |
| 01/19/2010 | US7649080 Reacting vancomycin with a coupling reagent, then reacting with a cephalosporin derivative; making antibiotic effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA) |